{"url_path":"/sec/cik-0001273087/13dg/2026-05-12/000110465926059524","section_key":"body","section_title":"SCHEDULE 13G body","topic":"sec","document":{"doc_type":"SCHEDULE 13G","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1273087/0001104659-26-059524-index.html","accession_number":"0001104659-26-059524","cik":"0001273087","ticker":null,"issuer_name":"MILLENNIUM MANAGEMENT LLC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1273087/0001104659-26-059524-index.html","primary_entity_key":"0001273087","primary_entity_name":"MILLENNIUM MANAGEMENT LLC"},"word_count":160,"has_tables":true,"body_markdown":"EX-99.1\n2\ntm2614383d1_ex-1.htm\nEXHIBIT 1\n\nEXHIBIT I\n\nJOINT FILING AGREEMENT\n\nThis will confirm the agreement by and among the undersigned that the\nSchedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by\nthe undersigned of the Class A Common Stock, par value $0.01 per share, of Maravai LifeSciences Holdings, Inc. will be filed on behalf\nof each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.\nThis Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall\nconstitute one and the same instrument.\n\nDated: May 11, 2026\n\nMILLENNIUM MANAGEMENT LLC\n\nBy:\n/s/ Gil Raviv\n\nName: Gil Raviv\n\nTitle: Global General Counsel\n\nMILLENNIUM GROUP MANAGEMENT LLC\n\nBy:\n/s/ Gil Raviv\n\nName: Gil Raviv\n\nTitle: Global General Counsel\n\n/s/ Israel A. Englander\n\nIsrael A. Englander"}